Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

103.00
BATS BZX Real-Time Price
As of 3:23pm ET
 -2.83 / -2.67%
Today’s Change
93.05
Today|||52-Week Range
128.39
-13.99%
Year-to-Date
Will Celgene Depose Biogen to Become Top Dog In Multiple Sclerosis?
Sep 28 / MotleyFool.com - Paid Partner Content
Allergan's Vitae buy could spark more interest in Kadmon
Sep 23 / TheStreet.com - Paid Partner Content
The 3 Best-Run Companies in the Healthcare Sector
Sep 27 / MotleyFool.com - Paid Partner Content
The Most Exciting Drug in Celgene's Pipeline
Sep 21 / MotleyFool.com - Paid Partner Content
Amgen Multiple Myeloma Drug Kyprolis Fails to Help Newly Diagnosed Patients
Sep 27 / TheStreet.com - Paid Partner Content
3 Top Stocks on Sale This Fall
Sep 19 / MotleyFool.com - Paid Partner Content
Biotech ETFs May Be a Prescription for Investment Success, Especially If Trump Become...
Sep 26 / TheStreet.com - Paid Partner Content
5 Reasons Celgene Is a Buy
Sep 15 / MotleyFool.com - Paid Partner Content
3 Top Biotech Stocks to Buy on Sale
Sep 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close105.83
Today’s open105.75
Day’s range102.32 - 106.30
Volume294,946
Average volume (3 months)4,278,795
Market cap$82.0B
Dividend yield--
Data as of 3:23pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+22.51%
Earnings growth (next 5 years)+20.49%
Revenue growth (last year)+16.47%
P/E ratio43.2
Price/Sales11.10
Price/Book14.06

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.80-2.38%
NVONovo Nordisk-1.82-4.16%
LLYEli Lilly and Co-0.89-1.10%
BMYBristol-Myers Squibb-1.20-2.18%
Data as of 3:23pm ET, 09/29/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$1.48
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts

Search for Jobs